SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003917
Filing Date
2021-11-10
Accepted
2021-11-10 07:31:41
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-20210930.htm   iXBRL 10-Q 1922243
2 EX-10.2 grtx-ex10_2.htm EX-10.2 216759
3 EX-10.3 grtx-ex10_3.htm EX-10.3 218111
4 EX-31.1 grtx-ex31_1.htm EX-31.1 17329
5 EX-31.2 grtx-ex31_2.htm EX-31.2 18836
6 EX-32.1 grtx-ex32_1.htm EX-32.1 9790
7 EX-32.2 grtx-ex32_2.htm EX-32.2 8641
  Complete submission text file 0000950170-21-003917.txt   6864031

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grtx-20210930.xsd EX-101.SCH 38761
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grtx-20210930_lab.xml EX-101.LAB 329017
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grtx-20210930_pre.xml EX-101.PRE 221937
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grtx-20210930_def.xml EX-101.DEF 96240
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grtx-20210930_cal.xml EX-101.CAL 36080
13 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20210930_htm.xml XML 1138500
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 211394413
SIC: 2834 Pharmaceutical Preparations